Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise
- 1 August 1988
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 20 (2) , 231-238
- https://doi.org/10.1016/0167-5273(88)90267-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Ischemic ST-segment changes after dipyridamole infusionInternational Journal of Cardiology, 1987
- Safety of intravenous dipyridamole for stress testing with thallium imagingThe American Journal of Cardiology, 1987
- Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man.Circulation, 1985
- Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosineActa Physiologica Scandinavica, 1984
- Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion.Circulation, 1982
- Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery diseaseThe American Journal of Cardiology, 1981
- Clinical significance of upsloping ST segments in exercise electrocardiography.Circulation, 1980
- Assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatationThe American Journal of Cardiology, 1978
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatationThe American Journal of Cardiology, 1978
- Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologie coronary vasodilatationThe American Journal of Cardiology, 1978